Efficacy and safety of sintilimab plus pemetrexed and platinum as first-line treatment for locally advanced or metastatic nonsquamous non-small cell lung cancer: a randomized, double-blind, phase 3 study (ORIENT-11).
暂无分享,去创建一个
Ying Cheng | B. Han | Baolan Li | Yanqiu Zhao | Yingyi Wang | Wei-min Li | N. Yang | Gong-yan Chen | Li Zhang | C. Xie | Yun-peng Yang | Jianying Zhou | X. Ren | Jifeng Feng | You Lu | Zhuang Yu | Zhehai Wang | S. Cang | Hui Zhou | Shuyan Wang | Donglei Zhu | W. Zhang | Yong Song | Zhiyong He | Qitao Yu | R. Ma | Juan Li | Zhi-Xiong Yang | M. Bi | Yan Zhang | Lijun Wang | X. Mei | J. Fang | R. Zhou | Gongyan Chen | C. Xie | Yunpeng Yang